faricimabum
[6-chloro-1-[2-(dimethylamino)ethyl]-2,3-dihydroindol-3-yl]-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylmethanone
Molecular Identity
faricimabum
[6-chloro-1-[2-(dimethylamino)ethyl]-2,3-dihydroindol-3-yl]-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylmethanone
PubChem CID: 91827367
2D Structure
Properties
C25H30ClN3O2
Molecular Formula
440.00
Molecular Weight
g/mol
439.2027
Exact Mass
Da
3.2
XLogP
Drug-like (Lipinski: < 5)
36
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
4
H-Bond Acceptors
651
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(16)
faricimabumVabysmofaricimab-svoaRG7716RefChem:58354Y8ha1i28d3QC4F7FKK7IRG-77161607793-29-2RO6867461RO-6867461RG-7716 (antivascular endothelial growth factor/anti-angiopoietin 2 bispecific antibody)GTPL8529SCHEMBL29500934RG-7713
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to faricimabum
Loading drug network...